FDA 483 - KEDPLASMA LLC - December 16, 2025

An FDA inspection of KEDPLASMA LLC in Indianapolis, IN, revealed two significant observations. The firm failed to correctly label Source Plasma containers with the total plasma volume and exhibited a critical lapse in aseptic technique during blood collection, where a phlebotomist contaminated a sterile venipuncture site.